Sen-Jam Pharmaceutical

🚀 Strategic Partnering in Motion + Webinar Invite + 2 Weeks Left to Invest

Jim Iversen

Published 2 days ago

Hi everyone!

We’ve got big news to share as we enter the final stretch of our Wefunder campaign…

👉 Strategy in Motion

Destum Partners is now actively leading our global search for strategic partners to license, co-develop, or acquire our lead asset, SJP-001 — the world’s first anti-inflammatory solution for the overindulgence of food and drink.

With over $5B in deals closed, Destum is one of the top names in biotech partnering — and they believe in what we’re building.

đź“„ Check out our brand new non-confidential deck for SJP-001 here

Exclusive Webinar this Thursday

🗓️ JOIN US THIS THURSDAY at 5pm ET for a live webinar with Destum's Managing Directors, Gareth Lugg and Matt Vanderberg. They’ll walk us through their outreach strategy, progress so far, and what comes next.

🎥 Zoom/Webinar Registration Link

đź’° Only 2 Weeks Left!

Our Wefunder round closes April 7th. If you’ve been watching from the sidelines, now is the time to jump in — or increase your investment if you’ve already joined us.

Let’s finish strong 💪

đź“… Want to chat with me directly? Grab time here:

👉 Book time on my calendar

Thank you for believing in Sen-Jam and our mission to disrupt inflammation and improve lives.

Jim


You're the first one here!

Early people don't usually get a prize, so here's a love letter from us.